PERISCOPE CAPITAL INC. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 68 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3,004,720
-39.4%
297,500
-40.5%
0.13%
-10.4%
Q3 2022$4,960,000
+0.2%
499,700
-0.1%
0.14%
+9.1%
Q2 2022$4,950,000
-33.9%
499,998
-34.1%
0.13%
-31.2%
Q1 2022$7,483,000
+0.2%
758,900
-0.0%
0.19%
-4.0%
Q4 2021$7,471,000
+1.0%
759,269
-0.1%
0.20%
-9.1%
Q3 2021$7,400,000
+0.7%
759,800
-0.0%
0.22%
-8.3%
Q2 2021$7,349,000
+208.0%
760,000
+209.6%
0.24%
+155.3%
Q1 2021$2,386,000245,5060.09%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2022
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders